난소 갑상선종에서 기원한 유두상 갑상선암종: 증례 보고 1예 및 문헌 고찰
PAPILLARY TYPE THYROID CARCINOMA ORIGINATING IN STRUMA OVARII: CASE REPORT AND REVIEW OF THE LITERATURE
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
난소 종양의 약 15-20%는 기형종이 차지하고 있다. 난소 갑상선종은 기형종의 일종으로 갑상선 조직이 우세한 구성 성분으로 이루어졌다. 이는 모든 기형종의 약 2%를 차지하는 드문 종양이며 특히 악성 형질전환을 보이는 것은 전체 난소 갑상선종의 5%에 미친다. 악성 난소 갑상선종 중 유두상 암종이 가장 흔하게 관찰된다. 하지만 악성 종양의 희귀성 때문에 치료가 정확히 확립되어 있지 않다. 본 저자들은난소 부속기 종양을 주소로 내원한 폐경기 여자에서 복강경을 이용하여 난소난관제거술을 시행한 후, 조직학적으로 난소 갑상선종에서 기원한 유두상 갑상선암종으로 진단된 증례를 경험하였다. 이에 간단한 문헌 고찰과 함께 보고하는 바이다.
Abstract
About 15-20% of ovarian tumors are teratomas. Struma ovarii is a highly specialized form of ovarian teratoma, in which thyroid tissue is the predominant element. It is rare, comprising about 2% of all teratomas, and malignant transformation occurs in less than 5% of struma ovarii. Among the malignant struma ovarii, papillary type is the most common histologic type. However,because of the rarity of malignant struma ovarii, there is considerable confusion concerning management. Recently, the authors experienced a case of papillary thyroid carcinoma arising in struma ovarii found in a postmenopausal woman who presented with adnexal mass and underwent laparoscopic unilateral salpingoophorectomy. Therefore, we report this rare case with a brief review of the literature.
참고문헌 (15)
- Novak ER, "Gynecologic and obstetric pathology: with clinical and endocrine relations. 8th ed" (1979), Saunders
- Boettlin R, "Uber zahnentwickelung in dermoid cysten des ovariums", Virchows Arch Path Arat, 115, pp.493~504 (1889)
- Gottschalk S, "Ein neuer typus einer kleincystischen bosrtigen eierstockgeschwulst", Arch Gynak, 59, pp.676~698 (1899)
- Roth LM, "Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis", Int J Gynecol Pathol, 27, pp.213~222 (2008)
- Berek JS, "Practical gynecologic oncology. 3rd ed" (2003), Lippincott Williams & Wilkins
- Serov SF, "Histological typing of ovarian tumors", International histological classifi cation and staging of tumors. No. 9 (1973), World Health Organization
- Rosenblum NG, "Malignant struma ovarii", Gynecol Oncol, 32, pp.224~227 (1989)
- Miyazaki K, "Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary", Obstet Gynecol, 78, pp.562~566 (1991)
- Balci TA, "Is the I-131 whole-body scanning proper for follow-up management of the patients with malignant struma ovarii without performing the thyroidectomy", Gynecol Oncol, 99, pp.520~ (2005)
- O’Neill JP, "Papillary type thyroid carcinoma in an ovarian struma", Ir J Med Sci (2010)[DOI]
- Hirakawa T, "Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Clinicopathologic and topographic analysis", Am J Surg Pathol, 13, pp.397~405 (1989)
- Pardo-Mindan FJ, "Malignant struma ovarii. Light and electron microscopic study", Cancer, 51, pp.337~343 (1983)
- Roth LM, "Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature", Int J Gynecol Pathol, 27, pp.496~506 (2008)
- Makani S, "Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature", Gynecol Oncol, 94, pp.835~839 (2004)
- Devaney K, "Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases", Int J Gynecol Pathol, 12, pp.333~343 (1993)